drugset / Trial / NCT01927055
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
RandomizedParallel-groupTriple-blindTreatment
Summary
Evaluate the clinical efficacy and safety of droxidopa versus placebo over a 17 week (maximum) treatment period in patients with symptomatic NOH.
Timeline
- Start
- 2013-11
- Primary completion
- 2015-02
- Completion
- 2015-02
Outcome
Outcome not reported
Stopped: “Due to potential competition with a post-marketing study requested by FDA”